2012•Biaoji mianyi fenxi yu linchuangRequires access

Detection of AFP-L3 in Diagnosis of Hepatocellular Carcinoma

Zhou Xiuyan

Open publisher page 0 citations

Abstract

Objective To explore of clinical value of AFP-L3 in the diagnosis of patients with HCC.Methods The serum AFP-L3 levels in 137 patients with elevated AFP level were detected by ELISA.The patients were divided into HCC group and benign liver disease group.Results The serum levels of AFP-L3 in patients with HCC(109.04±62.51ng/mL) were significantly higher than those patients with benign liver diseases(25.96±49.43ng/mL,P0.001).The area under the ROC curve of AFP-L3 level in patients with HCC was 0.819.Taking AFP-L3 level ≥37.9ng/mL as diagnostic criteria,the sensitivity of AFP-L3 level in HCC diagnosis was 83.7%,and the specificity was 88.9%,with a total conformity rate of 85.4% compared to the confirmed clinical diagnosis.Conclusion The serum AFP-L3 levels might be a valuable biomarker in diagnosis and prediction of prognosis of HCC.The detection of AFP-L3 level by using ELISA is simple and cost-effective method.

About this research paper

What this paper is about

Objective To explore of clinical value of AFP-L3 in the diagnosis of patients with HCC.Methods The serum AFP-L3 levels in 137 patients with elevated AFP level were detected by ELISA.The patients were divided into HCC group and benign liver disease group.Results The serum levels of AFP-L3 in patients with HCC(109.04±62.51ng/mL) were significantly higher than those patients with benign liver diseases(25.96±49.43ng/mL,P0.001).The area under the ROC curve of AFP-L3 level in patients with HCC was 0.819.Taking AFP-L3 level ≥37.9ng/mL as diagnostic criteria,the sensitivity of AFP-L3 level in HCC diagnosis was 83.7%,and the specificity was 88.9%,with a total conformity rate of 85.4% compared to the confirmed clinical diagnosis.Conclusion The serum AFP-L3 levels might be a valuable biomarker in diagnosis and prediction of prognosis of HCC.The detection of AFP-L3 level by using ELISA is simple and cost-effective method.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Objective To explore of clinical value of AFP-L3 in the diagnosis of patients with HCC.Methods The serum AFP-L3 levels in 137 patients with elevated AFP level were detected by ELISA.The patients were divided into HCC group and benign liver disease group.Results The serum levels of AFP-L3 in patients with HCC(109.04±62.51ng/mL) were significantly higher than those patients with benign liver diseases(25.96±49.43ng/mL,P0.001).The area under the ROC curve of AFP-L3 level in patients with HCC was 0.819.Taking AFP-L3 level ≥37.9ng/mL as diagnostic criteria,the sensitivity of AFP-L3 level in HCC diagnosis was 83.7%,and the specificity was 88.9%,with a total conformity rate of 85.4% compared to the confirmed clinical diagnosis.Conclusion The serum AFP-L3 levels might be a valuable biomarker in diagnosis and prediction of prognosis of HCC.The detection of AFP-L3 level by using ELISA is simple and cost-effective method.

Key concepts: Medicine, Hepatocellular carcinoma, Internal medicine, Gastroenterology, Biomarker, Alpha-fetoprotein, Clinical diagnosis, Biochemistry

Related papers

Back to paper searchBrowse research topicsOriginal source
Detection of AFP-L3 in Diagnosis of Hepatocellular Carcinoma — Research Paper | ScholarLens